Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland

[1]  M. Sadkowska-Todys,et al.  Data-driven case fatality rate estimation for the primary lineage of SARS-CoV-2 in Poland , 2022, Methods.

[2]  J. Tomažič,et al.  National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region , 2021, HIV medicine.

[3]  P. Goryński,et al.  Characteristics and Clinical Outcomes of 116,539 Patients Hospitalized with COVID-19—Poland, March–December 2020 , 2021, Viruses.

[4]  J. Polańska,et al.  Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study , 2021, Journal of inflammation research.

[5]  Munn Sann Lye,et al.  COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis , 2021, International journal of environmental research and public health.

[6]  V. Chinchilli,et al.  Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis , 2021, Scientific Reports.

[7]  H. Forman,et al.  SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut , 2021, The American Journal of Medicine.

[8]  H. Merchant,et al.  COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK , 2021, Expert review of respiratory medicine.

[9]  David R. Holtgrave,et al.  COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State , 2021, JAMA network open.

[10]  K. Anastos,et al.  Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19. , 2021, Journal of acquired immune deficiency syndromes.

[11]  K. Bibbins-Domingo,et al.  Excess mortality associated with the COVID-19 pandemic among Californians 18–65 years of age, by occupational sector and occupation: March through November 2020 , 2021, medRxiv.

[12]  Kłos,et al.  Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study , 2021 .

[13]  J. Pell,et al.  Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants , 2020, Occupational and Environmental Medicine.

[14]  P. Glasziou,et al.  Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. , 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

[15]  Ye Yuan,et al.  Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities , 2020, Aging.

[16]  C. Akdis,et al.  Risk factors for severe and critically ill COVID‐19 patients: A review , 2020, Allergy.

[17]  M. Pawłowska,et al.  Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study , 2020, medRxiv.

[18]  R. Matulionytė,et al.  The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe , 2020, International Journal of Infectious Diseases.

[19]  A. Greenberg,et al.  SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV. , 2020, AIDS reviews.

[20]  A. Horban,et al.  The Case Series of 34 Patients with COVID-19 Diagnosed with HIV Infection from Central and Eastern European Countries – Euroguidelines in Central and Eastern Europe Network Group Data , 2020 .

[21]  O. Kirk,et al.  2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 , 2020, HIV medicine.

[22]  W. Mcfarland,et al.  COVID-19 Among People Living with HIV: A Systematic Review , 2020, AIDS and Behavior.

[23]  A. Horban,et al.  HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe? , 2020, International Journal of Infectious Diseases.

[24]  M. Bickel,et al.  COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients , 2020, Infection.

[25]  A. Horban,et al.  Long‐term trends in HIV care entry: over 15 years of clinical experience from Poland , 2019, HIV medicine.

[26]  E. Sprinz,et al.  Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: A cross-sectional study. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[27]  O. Kirk,et al.  Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration , 2014, The Lancet.

[28]  W. Witkiewicz,et al.  Występowanie nadwagi, otyłości i niedoboru masy ciała u pacjentów zakażonych HIV , 2013 .

[29]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[30]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.